Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore the primary drivers of risk in Dividend Aristocrats ETF, including sector shifts and interest-rate impacts, with practical mitigation tips.
26,217 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Hyperliquid’s hip-3 markets surge has pushed HIP-3’s share of perpetual futures volume to roughly half, signaling a d...
BitMine posted a strong ETH staking quarter, but a large derivatives loss erased gains, underscoring risk in its Ethe...
As crypto markets face renewed volatility, USDT and USDC remain the two dominant stablecoins. This article weighs res...
AD Mortgage has sent a policy letter to the FHFA raising concerns about proposed condo financing criteria changes for...
Intel stock has moved faster than its turnaround plan in many eyes. As Lip-Bu Tan reshapes the company, investors mus...
A widening split on who can afford a home is reshaping the housing landscape. This article breaks down why the divide...
The Mexican army killed cartel chief El Mencho in a late Sunday operation, prompting airlines to suspend flights to P...
A Gartner forecast signals a seismic shift: 40% of enterprise apps will embed AI agents by 2026. This article breaks ...
stifel just predicted bitcoin could fall toward $38,000, a chart-based call rooted in 15-year crash bottoms that has ...
Dream of four rental properties by 40? This real-world guide shows a clear path—from loans to cash flow—to turn that ...
Ethereum closes a seventh consecutive red month as whales reel in risk, even as on-chain Real World Assets push past ...